ID: ALA5199934

Max Phase: Preclinical

Molecular Formula: C29H39FN2O5

Molecular Weight: 514.64

Representations

Canonical SMILES:  C=C[C@]1(C)C[C@@H](OC(=O)CNC(=O)Nc2ccc(F)cc2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O

Standard InChI:  InChI=1S/C29H39FN2O5/c1-6-27(4)15-22(37-23(34)16-31-26(36)32-20-9-7-19(30)8-10-20)28(5)17(2)11-13-29(18(3)25(27)35)14-12-21(33)24(28)29/h6-10,17-18,22,24-25,35H,1,11-16H2,2-5H3,(H2,31,32,36)/t17-,18+,22-,24+,25+,27-,28+,29+/m1/s1

Standard InChI Key:  INRAZYRSDLNZHQ-QEBHMZMPSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 514.64

Molecular Weight (Monoisotopic): 514.2843

AlogP: 4.85

#Rotatable Bonds: 5

Polar Surface Area: 104.73

Molecular Species: NEUTRAL

HBA: 5

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 13.72

CX Basic pKa:

CX LogP: 4.36

CX LogD: 4.36

Aromatic Rings: 1

Heavy Atoms: 37

QED Weighted: 0.38

Np Likeness Score: 0.88

References

1. Wu G, Zhu Z, Li J, Luo X, Zhu W, Liao G, Xia J, Zhang W, Pan W, Li T, Wu S..  (2022)  Design, synthesis and antibacterial evaluation of pleuromutilin derivatives.,  59  [PMID:35220163] [10.1016/j.bmc.2022.116676]

Source

Source(1):

• Scientific Literature